Chordate Medical Holding AB (publ)
Stockholm Stock Exchange CMH.ST
Chordate Medical Holding AB (publ) Price to Book Ratio (P/B) on January 14, 2025
Chordate Medical Holding AB (publ) Price to Book Ratio (P/B) is NA on January 14, 2025, a NA change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.
-
Chordate Medical Holding AB (publ) 52-week high Price to Book Ratio (P/B) is NA on January 14, 2025, which is NA below the current Price to Book Ratio (P/B).
-
Chordate Medical Holding AB (publ) 52-week low Price to Book Ratio (P/B) is NA on January 14, 2025, which is NA below the current Price to Book Ratio (P/B).
-
Chordate Medical Holding AB (publ) average Price to Book Ratio (P/B) for the last 52 weeks is NA.
Key data
| Date | Price to Book Ratio (P/B) | Dividend Yield | Free Cash Flow Yield | Price to Earnings Ratio (P/E) |
|---|
Market news
Loading...
Stockholm Stock Exchange: CMH.ST
| CEO | Mr. Anders Weilandt |
| IPO Date | Feb. 15, 2022 |
| Location | Sweden |
| Headquarters | KistagAngen 20B |
| Employees | 3 |
| Sector | Health Care |
| Industries | |
Description
Chordate Medical Holding AB (publ), a medical technology company, develops products and solutions for the treatment of chronic migraine and rhinitis in Sweden. It focuses on the ear-nose and throat area. The company was founded in 2005 and is based in Kista, Sweden.
Key trends
Past 5 years
Similar companies
Clinical Laserthermia Systems AB (publ)
USD 0.28
-7.61%
StockViz Staff
January 15, 2025
Any question? Send us an email